Company news
Masimo Corporation news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
December 17, 2023
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
December 10, 2023
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
November 26, 2023
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
November 16, 2023
Masimo to Present in Jefferies London Healthcare Conference
November 8, 2023
GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform
November 7, 2023
Masimo Reports Third Quarter 2023 Financial Results
November 6, 2023
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
October 25, 2023
Masimo to Report Third Quarter 2023 Financial Results after Market Close on Tuesday, November 7
October 23, 2023
Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
October 12, 2023
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
October 8, 2023
Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring Agreement
August 30, 2023
Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor
August 22, 2023
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
August 20, 2023
Masimo Reports Second Quarter 2023 Financial Results
August 7, 2023
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
August 6, 2023
Masimo Announces Preliminary Second Quarter 2023 Revenue Results
July 16, 2023
Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
June 21, 2023
Masimo and Clinton Foundation Host Roundtable Addressing Overdose and Addiction Crisis
June 20, 2023
Masimo Expands Into the Personalized Hearables Market with Denon PerL™ True Wireless Earbuds, Featuring Masimo Adaptive Acoustic Technology™ (AAT™)
June 19, 2023
Masimo Board of Directors Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card
June 19, 2023
Masimo Board of Directors Highlights Value of Company’s Mission-Driven Innovation in Letter to Stockholders
June 12, 2023
Community Health System Expands Use of Multiple Masimo Technologies, System-wide
June 11, 2023
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
June 7, 2023
Masimo Chairman and CEO Joe Kiani Waives Rights Under Director Change-in-Control Provision
June 5, 2023
Masimo to Present in Jefferies Healthcare Conference
June 4, 2023
Masimo Announces FDA 510(k) Clearance of Radius VSM™
June 4, 2023
Masimo Board of Directors Authorizes Appointment of Michelle Brennan as Sixth Director Pending Stockholder Approval of Board Expansion and Election of Company Nominees
June 1, 2023
Masimo Board of Directors Sets the Record Straight on False and Misleading Claims
May 31, 2023
Masimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s Agenda
May 30, 2023
Masimo Announces Major Expansion of the HEOS® Platform
May 23, 2023
Orange County Business Journal Names Masimo’s Micah Young CFO of the Year
May 11, 2023
Masimo Reports First Quarter 2023 Financial Results
May 8, 2023
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
May 7, 2023
Masimo Stork™ Delivers State-of-the-Art Baby Monitoring to the Home
April 30, 2023
Masimo to Report First Quarter 2023 Financial Results After Market Close on Tuesday, May 9
April 24, 2023
Masimo Announces FDA Clearance of the Rad-G® with Temperature
April 17, 2023
Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System
April 2, 2023
Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch
March 27, 2023
Masimo Announces Changes to Governance Structure and Practices
March 22, 2023
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
March 14, 2023
New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
March 8, 2023
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
March 6, 2023
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
March 5, 2023
Masimo to Present in 44th Annual Raymond James Institutional Investors Conference
March 1, 2023
Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results
February 27, 2023
New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
February 20, 2023
Masimo Centroid® Receives Innovative Technology Designation from Vizient
February 14, 2023
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
February 13, 2023
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
January 29, 2023
Calls
The 5 newest of 19 calls. Every call is listed under its year.
- Masimo (NASDAQ:MASI) Q3 2025 Earnings Call
Nov 4, 2025
Transcript - Masimo (NASDAQ:MASI) Q2 2025 Earnings Call
Aug 5, 2025
Transcript - Masimo (NASDAQ:MASI) Q1 2025 Earnings Call
May 6, 2025
Transcript - Masimo (NASDAQ:MASI) Q4 2024 Earnings Call
Feb 25, 2025
Transcript - Masimo (NASDAQ:MASI) Q3 2024 Earnings Call
Nov 5, 2024
Transcript
Decks
The 5 newest of 71 decks. Every deck is listed under its year.
- J.P. Morgan Healthcare Conference 2026
Conference · 19 slides · Jan 12, 2026
- Investor Day (December 2025)
Investor day · 78 slides · Dec 3, 2025
- Investor Day (December 2025)
Investor day · 22 slides · Dec 3, 2025
- Q3 2025 Earnings Presentation
Earnings · 11 slides · Nov 4, 2025
- Q2 2025 Earnings Presentation
Earnings · 12 slides · Aug 5, 2025